CONTINUING MEDICAL EDUCATION:
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Imedex, LLC designates this educational activity for a maximum of 18.25 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

WHO SHOULD ATTEND:
This educational activity is intended for physicians, nurses and other health care practitioners involved or interested in the management of patients with cancer.

 

OBJECTIVES:
After successful completion of this course, attendees should be able to:
• Develop a comprehensive approach to the state of the art management of lung, breast, head and neck, gynecologic, gastrointestinal, genitourinary cancers, hematologic malignancies and sarcomas
• Integrate the latest advances in molecularly targeted therapy, chemotherapy, radiotherapy and surgical options for patients with malignancies into clinical practice
• Provide an in-depth description of current and emerging therapeutic options including their development and utility in cancer management
• Describe the role of medical imaging and informatics in cancer diagnosis and treatment
• Identify and manage supportive care and symptom management issues involved in caring for patients with cancer
• Discuss the rationale for the development of new cancer treatments based on underlying molecular mechanisms

Diponkar Banerjee, MBChB, PhD British Columbia Cancer Agency Vancouver, British Columbia, Canada Michael Barton, MB South West Sydney Clinical School University of New South Wales Sydney, Australia Jerry J. Battista, PhD London Regional Cancer Centre London, Ontario, Canada Robert Bell, MD University Health Network University of Toronto Toronto, Ontario, Canada Andrea Bezjak, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Martin Blackstein, MD, PhD Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada James Brenton, MD University of Cambridge Cambridge, United Kingdom Patrice Bret, MD University Health Network University of Toronto Toronto, Ontario, Canada Robert G. Bristow, MD, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Kristy Brock, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Rena Buckstein, MD Sunnybrook Odette Cancer Centre University of Toronto Toronto, Ontario, Canada Ann Chambers, PhD London Health Sciences Centre London, Ontario, Canada Eric X. Chen, MD, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Peter Chung, MBChB Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Mark Clemons, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Allan Covens, MD Sunnybrook Odette Cancer Centre University of Toronto Toronto, Ontario, Canada Michael Crump, MD Princess Margaret Hospital University of Toronto Toronto, Ontario Canada Bernard Cummings, MBChB Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Alastair Cunningham, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada John R. Cunningham, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Laura A. Dawson, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Susan Done, MBBChir, PhD Ontario Cancer Institute University of Toronto Toronto, Ontario, Canada Diane Doran, PhD, RN University of Toronto Toronto, Ontario, Canada William K. Evans, MD Juravinski Cancer Centre Hamilton Health Sciences Hamilton, Ontario, Canada Ronald Feld, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Peter Ferguson, MD Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada Anthony Finelli, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Neil Fleshner, MD, MPH Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Michael Friedlander, MD University of New South Wales and Prince of Wales Hospital Sydney, Australia Anthony Fyles, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Steven Gallinger, MD Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada David Gianfelice, MD Toronto General Hospital University of Toronto Toronto, Ontario, Canada Ralph Gilbert, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Mary K. Gospodarowicz, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Esther Green, RN Cancer Care Ontario University of Toronto Toronto, Ontario, Canada

Abha Gupta, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada David W. Hedley, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Richard Hill, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Hal W. Hirte, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada David Hodgson, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada David Hogg, MD Toronto General Research Institute University of Toronto Toronto, Ontario, Canada Doris Howell, PhD, RN Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Alan Hudson, MD Cancer Care Ontario University of Toronto Toronto, Ontario, Canada Jonathan C. Irish, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Alexandro Jadad, MD, DPhil Toronto General Research Institute University of Toronto Toronto, Ontario, Canada David Jaffray, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Michael Jewett, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Kartik Jhaveri, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Michael R. Johnston, MD Dalhousie University Halifax, Nova Scotia, Canada Erin Kennedy, MD Toronto General Hospital University of Toronto Toronto, Ontario, Canada Rama Khokha, PhD Ontario Cancer Institute University of Toronto Toronto, Ontario, Canada John Kim, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Jennifer Knox, MD, MSc Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Vickie Kong, MRT(T) Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Anne Lee, MD Pamela Youde Nethersole Eastern Hospital Chai Wan, Hong Kong Fei Fei Liu, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada William Mackillop, MD Queen’s University Kingston, Ontario, Canada Leon Massuger, MD, PhD Radboud University Medical Centre Nijmegen, The Netherlands David McCready, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Sandra Mitchell, CRNP, AOCN, PhD National Institute of Health Bethesda, Maryland, United States Faye Montgomery, MRT(T) Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Malcolm J. Moore, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Joan Murphy, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Ole Nielsen, MD Aarhus University Hospital Aarhus, Denmark Pam Ohashi, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Amita Oza, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada David Payne, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Bayardo Perez-Ordonez, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Eugenia Piliotis, MD Sunnybrook Odette Cancer Centre University of Toronto Toronto, Ontario, Canada

Kathleen I. Pritchard, MD Sunnybrook Odette Cancer Centre University of Toronto Toronto, Ontario, Canada Michael Rauth, PhD Princes Margaret Hospital University of Toronto Toronto, Ontario, Canada Donna Reece, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Jolie Ringash, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Heidi Roberts, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Gary Rodin, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Barry Rosen, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Peter Selby, MD Leeds Institute of Molecular Medicine St James University Hospital Leeds, United Kingdom Patricia Shaw, MD Toronto General Hospital University of Toronto Toronto, Ontario, Canada Frances A. Shepherd, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Dietmar Siemann, PhD University of Florida College of Medicine Gainesville, Florida, United States Lillian L. Siu, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Joyce Slingerland, MD, PhD University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States Jeremy Sturgeon, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Terrence Sullivan, PhD Cancer Care Ontario University of Toronto Toronto, Ontario, Canada Simon Sutcliffe, MD British Columbia Cancer Agency Vancouver, British Columbia, Canada Carol Swallow, MD, PhD Mount Sinai Hospital University of Toronto Toronto, Ontario, Canada Ian Tannock, MD, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Bryce Taylor, MD Toronto General Hospital University of Toronto Toronto, Ontario, Canada Dan Theodorescu, MD, PhD Paul Mellon Urologic Cancer Institute University of Virginia Charlottesville, Virginia, United States Gillian Thomas, MD Sunnybrook Odette Cancer Centre University of Toronto Toronto, Ontario, Canada Lorenz Trümper, MD, PhD University of Göttingen Göttingen, Germany Richard Tsang, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada John Waldron, MD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Padraig Warde, MB Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Robert Weersink, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada Terry West, BA, MRT(T) Princess Margaret Hospital Toronto, Ontario, Canada Timothy Whelan, MD Juravinski Cancer Centre Hamilton, Ontario, Canada William R. Wilson, PhD Auckland Cancer Society Research Centre The University of Auckland Auckland, New Zealand Shun Wong, MD Sunnybrook Odette Cancer Centre University of Toronto Toronto, Ontario, Canada John W. Wong, PhD John Hopkins University Baltimore, Maryland, United States Martin Yaffe, PhD Sunnybrook Odette Cancer Centre University of Toronto Toronto, Ontario, Canada Ivan Yeung, PhD Princess Margaret Hospital University of Toronto Toronto, Ontario, Canada John Zalcberg, MB, BS, PhD Peter MacCallum Cancer Institute Melbourne, Australia

Thursday, October 16, 2008

7:00 am
Registration and breakfast

8:00 am
Welcome and introductions

8:15 am
Session I: Keynote address
The Unexpected Consequences of Being a Research Fellow at PMH/OCI - Psychosocial and Proteomics
Peter Selby, MD

Session IIa: Recent advances in breast cancer
Moderator: Mark Clemons, MD
*Sessions IIa, IIb and IIc will run concurrently

9:00 am
Tailored adjuvant systemic therapy for breast cancer: Myth or reality?
Kathleen I. Pritchard, MD

9:20 am
Discussion

9:30 am
Recent and future developments in breast cancer imaging
Martin Yaffe, PhD

9:45 am
Rationale for targeting Src in breast cancer therapy
Joyce Slingerland, MD, PhD

10:00 am
Discussion

10:15 am
Coffee break

10:40 am
The evolution of sentinel lymph node biopsy
David McCready, MD

10: 55 am
Discussion

11:00 am
Classification of breast cancer in the molecular era
Susan Done, MBBChir, PhD

11:15 am
Discussion

11:20 am
Optimizing adjuvant radiation therapy for breast cancer
Timothy Whelan, MD

11:35 am
Discussion

11:40 am
Highlights of translational research from the Campbell Family Institute
Pam Ohashi, PhD

Session IIb: Recent advances in head and neck cancer
Moderators: Eric X. Chen, MD, PhD and Ralph Gilbert, MD

9:00 am
Advances in the management of nasopharyngeal cancer
Anne Lee, MD

9:45 am
Role of anatomic pathologists in molecular diagnosis of head and neck cancer
Bayardo Perez-Ordonez, MD

10:00 am
Coffee break

10:20 am
Translational research in head and neck cancer
Fei Fei Liu, MD

10:35 am
Molecular targeted approaches to head and neck cancer
Lillian L. Siu, MD

10:50 am
Quality of life in the era of chemoradiation
Jolie Ringash, MD

11:05 am
PET/CT for clinical decision making in the management of head and neck cancer
John Waldron, MD

11:20 am
Guided therapeutics: Innovations in head and neck surgical oncology
Jonathan C. Irish, MD

11:35 am
IMRT and Image guided radiotherapy in the management of head and neck cancer
John Kim, MD

11:50 am
Discussion

Session IIc: Recent advances in gynecologic cancers
Moderators: Amit Oza, MD and Barry Rosen, MD

Novel therapeutics in gynecologic cancers

9:00 am
Molecular studies in ovarian cancer
James Brenton,MD

9:30 am
Targeted therapy for gynecologic cancers
Amit Oza, MD

10:00 am
Coffee break

10:20 am
Biology response controversies and advances in BRCA related ovarian cancer: Lessons learned and future directions
Michael Friedlander, MD

Controversies in early endometrial cancer

10:40 am
Risk-adapted approach to surgical staging
Leon Massuger, MD, PhD

11:00 am
External beam RT or brachytherapy?
Gillian Thomas, MD

11:30 am
Debate: Women with high-risk early-stage endometrial cancer should receive adjuvant chemotherapy
In favour: Michael Friedlander, MD | Opposed: Hal W. Hirte, MD

12:00 pm
Lunch Symposium

1:30 pm
Session III: Keynote address: Oncology pathology – The past, the present and the future
Diponkar Banerjee, MBChB, PhD

Session IVa: Recent advances in lymphoma
Moderator: Michael Crump, MD
*Sessions IVa, IVb and IVc run concurrently

2:15 pm
Advances in biology and treatment of aggressive lymphomas
Lorenz Trümper, MD, PhD

3:15 pm
Coffee break

3:35 pm
Poster discussion

3:50 pm
The current role of radiation therapy in the treatment of lymphoma
Mary K. Gospodarowicz, MD

4:25 pm
The contemporary management of multiple myeloma
Donna reece, MD

5:00 pm
Panel discussion: Special considerations in extranodal lymphoma
Rena Buckstein, MD and Richard Tsang, MD

Surviving lymphoma: Late effects of therapy
David Hodgson, MD

Innovative therapy for T cell lymphoma
Eugenia Piliotis, MD

Session IVb: Recent advances in lung cancer
Moderators: Ronald Feld, MD and David Payne, MD

2:15 pm
Will CT screening reduce overall lung cancer mortality?
Heidi Roberts, MD

2:35 pm
Discussion

2:45 pm
Progress in mesothelioma
Michael R. Johnston, MD

3:05 pm
Discussion

3:15 pm
Coffee break

3:35 pm
Changing the cure rate of lung cancer with radiotherapy
Andrea Bezjak, MD

3:55 pm
Discussion

4:05 pm
Integrating molecular profiling into patient selection for lung cancer therapy
Frances A. Shepherd, MD

4:25 pm
Discussion

4:35 pm
Cost effectiveness of targeted therapy in lung cancer
William K. Evans, MD

4:55 pm
Discussion

5:05 pm
Clinical case discussion

5:25 pm
Discussion

Session IVc: Controversies in ovarian cancer
Moderators: Anthony Fyles, MD and Joan Murphy, MD

Image guided therapy and fertility-sparing surgery

2:15 pm
Sentinel node dissection in vulvar cancer
Leon Massuger, MD,PhD

2:40 pm
Fertility-sparing surgery in cervix cancer
Allan Covens, MD

3:15 pm
Coffee break

3:35 pm
Image-guided adaptive radiation therapy
Anthony Fyles, MD

4:00 pm
New paradigms in serous ovarian cancer
Patricia Shaw, MD

4:25 pm
Ovarian cancer prevention
Barry Rosen, MD

4:50 pm
Poster discussion
James Brenton, MD and Hal W. Hirte, MD

Friday, October 17, 2008

7:00 am
Registration and breakfast

8:00 am
Welcome and introductions

8:15 am
Session V: Keynote address—Achieving the achievable in cancer control
William Mackillop, MD

Session VIa: Challenges in cancer control
Moderator: Mary K. Gospodarowicz, MD
*Sessions VIa, VIb, VIc run concurrently

9:00 am
Managing the growing burden of cancer
Terrence Sullivan, PhD

9:15 am
Radiotherapy in low and middle income countries
Michael Barton, MB

9:30 am
Access, quality and information
Alan Hudson, MD

9:45 am
Discussion

10:00 am
Coffee break

Promising solutions
Moderator: David Jaffray, PhD

10:20 am
Molecular oncology and personalized medicine
Simon Sutcliffe, MD

10:45 am
The promise of modern imaging
Patrice Bret, MD

11:05 am
Promise of eHealth
Alexandro Jadad, MD, DPhil

11:30 am
Discussion

Session VIb: Recent advances in gastrointestinal malignancies
Moderators: Bryce Taylor, MD and Shun Wong, MD

9:00 am
The development and the future of chemoradiation in anal canal cancer
Bernard Cummings, MBChB

9:20 am
Quality of life and decision making in surgery for rectal cancer
Erin Kennedy, MD

9:40 am
MRI in the staging of rectal cancer
Kartik Jhaveri, MD

9:55 am
Discussion

10:00 am
Coffee break

10:20 am
Chemotherapy in advanced colorectal cancer
John Zalcberg, MB,BS, PhD

10:50 am
Pancreatic cancer genomics
Steven Gallinger, MD

11:05 am
Preclinical testing of novel treatments in pancreas cancer xenograft models
David W. Hedley, MD

11:20 am
Putting drug development into practice for pancreas cancer
Malcolm J. Moore, MD

11:35 am
High precision radiation therapy for cancers of the upper abdomen
Laura A. Dawson, MD

11:50 am
Discussion

Session VIc: Improving the patient experience
Moderators: Faye Montgomery, MRT(T) and Terry West, BA, MRT(T)

9:00 am
Patient-centered outcomes: Forward thinking care in a time of opportunity
Diane Doran, PhD, RN

9:30 am
Patient-family reported outcomes in cancer: Symptom experience
Doris Howell, PhD, RN

9:45 am
Oncology nursing: Leading the way Esther Green, RN

10:00 am
Coffee break

10:20 am
Determinants of functional performance in long-term survivors of allogeneic stem cell transplantation with chronic graft versus host disease
Sandra Mitchell, CRNP, PhD, AOCN

10:35 am
Acute toxicity for prostatectomy patients receiving intensity modulated radiotherapy
Vickie Kong, MRT(T)

10:50 am
The science of supportive care: A research framework for psychosocial oncology and palliative care
Gary Rodin, MD

11:05 am
The healing journey: Teaching self-healing to motivated cancer patients from 1980-2008
Alastair Cunningham, PhD

11:20 am
Panel discussion

12:00 pm
Lunch

1:30 pm
Session VII: Keynote address: Novel paradigms in personalized medicine and drug discovery for cancer
Dan Theodorescu, MD, PhD

Session VIIIa: Evolution in the management of genitourinary cancers at PMH
Moderators: Neil Fleschner, MD, MPH, Jennifer Knox, MD, and Jeremy Sturgeon, MD
*Sessions VIIIa, VIIIb and VIIIc run concurrently

Prostate cancer

2:15 pm
Prevention: From the unknown to the doable
Neil Fleshner, MD, MPH

2:35 pm
Evolution of chemotherapy for hormone refractory prostate cancer
Ian Tannock, MD, PhD

2:55 pm
Discussion

3:15 pm
Coffee break

Testicular cancer: Modern paradigm of a curable cancer

3:35 pm
Seminoma: “From more to less”
Padraig Warde, MB

3:50 pm
Non Seminoma: Evolving role of retroperitoneal lymph node dissection
Michael Jewett, MD

4:15 pm
Individualized cancer therapy
Robert G. Bristow, MD, PhD

4:35 pm
Discussion

Surgical management of kidney cancer: The legacy of the Robson nephrectomy

4:45 pm
From Robson to radiofrequency- evolution of surgical management of renal carcinoma
Anthony Finelli, MD

5:05 pm
Discussion

Session VIIIb: Impact and promise of technology and informatics
Moderators: John R. Cunningham, PhD and David Jaffray, PhD

2:15 pm
Opening remarks
John R. Cunningham, PhD and David Jaffray, PhD

2:30 pm
IMRT/IGRT: Intensity-modulated radiotherapy with image guidance
Jerry J. Battista, PhD

3:15 pm
Coffee break

3:35 pm
Surgical interventions
David Gianfelice, MD

“Rapid Fire”

4:20 pm
Image registration
Kristy Brock, PhD

4:35 pm
CT perfusion imaging
Ivan Yeung, PhD

4:50 pm
Integrating optical information with volumetric imaging
Robert Weersink, PhD

5:05 pm
Informatics and information
John W. Wong, PhD

Session VIIIc: Sarcoma
Moderators: Robert Bell, MD and David Hogg, MD

2:15 pm
Contributions of EORTC trials to the management of sarcoma
Ole Nielsen, MD

2:45 pm
Surgical considerations in extremity sarcoma
Peter Ferguson, MD

3:05 pm
Discussion

3:15 pm
Coffee break

3:35 pm
Radiotherapy considerations in extremity sarcoma
Peter Chung, MBChB

3:45 pm
Discussion

3:50 pm
Management of retroperitoneal sarcomas
Carol Swallow, MD, PhD

4:10 pm
Discussion

4:15 pm
Targeted therapy in management of gastrointestinal stromal tumours (GIST)
Martin Blackstein, MD, PhD

4:35 pm
Discussion

4:40 pm
Current status of chemotherapy for primary bone sarcomas
Abha Gupta, MD

5:00 pm
Discussion
David Hogg, MD

5:30 pm
Adjourn

Saturday, October 18, 2008

7:15 am
Registration and breakfast

8:00 am
Welcome and introductions

8:15 am
Session IX: Keynote address: The microenvironment of solid tumours and response to systemic treatment
Ian Tannock, MD, PhD

Session X: Tapping into the tumour microenvironment for therapeutic gain
Moderators: Richard Hill, PhD and Michael Rauth, PhD

9:00 am
Radiation activated molecules targeting hypoxic cells
William R. Wilson, PhD

9:15 am
Discussion

9:30 am
Vascular disruption and antiangiogenesis
Dietmar Siemann, PhD

9:45 am
Discussion

10:00 am
Coffee break

10:20 am
Imaging cells as they metastasize
Ann Chambers, PhD

10:50 am
Microenvironmental effects on carcinogenesis
Rama Khokha, PhD

11:20 am
Fifteen years of measuring hypoxia in cervical cancer: What have we learned?
Anthony Fyles, MD

11:50 am
Panel discussion

12:20 pm
Closing remarks

12:30 pm
Adjourn

Click here to submit abstracts

Participants interested in presenting data should submit abstracts online at www.imedex.com by August 26, 2008. Abstracts are subject to acceptance by the Scientific Committee.

Acceptance notifications and guidelines for poster presentation will be sent on September 10, 2008. Authors of accepted abstracts who have not registered will have until October 2, 2008 to do so at the rate of $295 CAD. After this date, abstracts without registered presenters will be disregarded.

Abstract Guidelines
• Follow the online instructions
• Abstracts must be written in English
• Accepted format: Word document format, 9 point Arial font, 500 word count limit
• Use a concise title
• List affiliations of author(s) as briefly as possible, with city, state and country
• Place an asterisk (*) before the name of the presenting author
• Use standard and well-accepted abbreviations
• When using references, use standard and well-accepted formats
• Abstract content should be single-spaced, typed in lower case and contain:
- Purpose of the study
- Summarized description of the project
- Results and conclusions

Submission Deadline: August 26, 2008

Click here to submit abstracts

REGISTRATION FEES

Physicians
Discounted $295 CAD
Payment received by August 14, 2008

Regular $395 CAD
Payment received by October 8, 2008

Full/Onsite $495 CAD
Payment received after October 8, 2008

Nurses/Residents*
Discount $175 CAD
Payment received by August 14, 2008

Regular $210 CAD
Payment received by October 8, 2008

Full/Onsite $245 CAD
Payment received after October 8, 2008

Students*
Discount $175 CAD
Payment received by August 14, 2008

Regular $210 CAD
Payment received by October 8, 2008

Full/Onsite $245 CAD
Payment received after October 8, 2008

Pharmacists*
Discounted $235 CAD
Payment received by August 14, 2008

Regular $320 CAD
Payment received by October 8, 2008
Full/Onsite $370 CAD
Payment received after October 8, 2008

* Proof of eligibility must accompany registration

REGISTRATION PROCEDURES
To Register: You may register online by October 8, 2008 or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting.

To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment: To pre-register, registration and payment must be received no later than October 8, 2008. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card or cheque. Cheques should be payable to Imedex. Attendee is not registered until full payment is received.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the announcement.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than October 8, 2008. The amount of registration fees remitted, minus a $75 CAD administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after October 8, 2008.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this conference should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Hilton Toronto
145 Richmond Street West
Toronto, Ontario, Canada M5H 2L2
Tel.: +1 (416) 869 3456
Fax: +1 (416) 869 3187

One of the most multicultural cities in the world, Toronto is marked by the diversity of distinct neighborhoods, cultures, and communities. The Hilton Toronto is located in the heart of the city's financial and vibrant entertainment districts. A short walk away are many well-known downtown sights such as the CN Tower, the Hockey Hall of Fame, the waterfront, and several sporting arenas. From the hotel, a subterranean walkway leads to over 1000 shops.

For the convenience of attendees, a limited number of rooms have been reserved until Tuesday, September 23, 2008 at a discounted rate of $229 CAD single/double occupancy, plus tax, currently at 5% provincial sales tax, 6% goods and services tax, and 3% destination marketing fee. This rate is not guaranteed outside the conference dates or after Tuesday, September 23, 2008.

To reserve your room please contact the Hilton Toronto reservations department at +1 (416) 869 3456 or visit the hotel’s website at www.toronto.hilton.com. To receive the group rate, callers must identify themselves as being with the 8th Princess Margaret Hospital Conference: Conquering Cancer in our Lifetime group. Internet users must enter the meeting promotional code: IMED08.. To receive the group rate, callers must identify themselves as being with the 8th Princess Margaret Hospital Conference: Conquering Cancer in our Lifetime group. Reservation requests received after Tuesday, September 23, 2008 may not be guaranteed the group rate.

To register for a hotel room and receive a discount for attending the meeting; please visit the hotels website http://www.hilton.com/en/hi/groups/personalized/TORHIHH-IMED08-20081011/index.jhtml

 

ORGANIZERS:
Pamela Catton, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Ronald Feld, MD
Princess Margaret Hospital
Toronto, Ontario, Canada

Richard Hill, PhD
Princess Margaret Hospital
Toronto, Ontario, Canada

 

SCIENTIFIC COMMITTEE:
Andrea Bezjak
James Brierley
Pamela Catton
Michael Crump
Bernard Cummings
Mary Elliott
Ronald Feld
Barbara Fitzgerald
Neil Fleshner
Anthony Fyles
Mary K. Gospodarowicz
Anna Greenberg
Richard Hill
Michael Jewett
David McCready
Hans A. Messner
Jeffrey Myers
Naomi Miller
Faye Montgomery
Martin O’Malley
Ian Quirt
Michael Sharpe
Frances A. Shepherd
Janice Stewart
Ian Tannock
John Waldron
David Warr

 

LETTER FROM THE ORGANIZERS:
Dear Colleague,
On behalf of the Organizing Committee, it is with great pleasure that we invite you to participate in The 8th Princess Margaret Hospital Conference, Developments in Cancer Management: Conquering Cancer in our Lifetime, to be held October 16-18, 2008 in Toronto, Ontario, Canada.  This year we are especially proud to be celebrating the 50th anniversary of the Princess Margaret Hospital and the Ontario Cancer Institute.

Year after year, this conference enjoys great success, as indicated by participant evaluations.  Attendees have offered praise for the quality of the scientific agenda and the speakers, and state that participation in the conference greatly enhances their knowledge of state-of-the-art cancer research and management.

This year, the Organizing Committee has created yet another excellent scientific agenda in conjunction with the Ontario Cancer Institute aimed at updating attendees on standard cancer therapies and new experimental programs, with in-depth examination of novel therapies and their future role in clinical practice. The general focus of the discussions will highlight how new information may apply to the treatment of cancer patients in your own institution or practice setting. The internationally renowned faculty includes members of the Princess Margaret Hospital community, one of the largest multidisciplinary cancer centres in North America and a pioneer in basic research and development of new cancer treatments.

PMH continues to be a leader in the cancer arena with alumni spread across the world, significantly impacting modern approaches to cancer research and management. As a result, PMH is happy to have their distinguished alumni from around the globe provide keynote lectures in various therapy areas within the field of oncology.

We are particularly proud to hold this meeting in the city of Toronto, one of the most beautiful and safest cities in North America.  Excellent museums and interesting sites abound throughout the city, which is also located less than two hours from Niagara Falls, one of the natural wonders of the world. Because of the city’s multicultural character, there are plenty of restaurant choices to sample cuisine that is among the best in the world. We hope you will make time to partake in all the city has to offer while updating your knowledge in state-of-the-art cancer research and management. 

We look forward to welcoming you to Toronto in October 2008!

Sincerely,

Pamela Catton, MD
Ronald Feld, MD
Richard Hill, PhD

 

Discounted Airfares
Contact Congress travel agent, Williamsburg Travel, for assistance with your travel needs. Williamsburg Travel can also accommodate pre- and
post-Congress extensions.
Tel.: +1 (888) 232 9394 or +1 (770) 261 8613
Email: judit@willtrav.com

 

Conference Location and Registration
The Registration and Information Desk will be staffed:

Thursday, October 16, 2008
7:00 am – 5:30 pm

Friday, October 17, 2008
7:00 am – 5:30 pm

Saturday, October 18, 2008
7:00 am – 12:30 pm

Hilton Toronto
145 Richmond Street West
Toronto, Ontario, Canada M5H 2L2
Tel.: +1 (416) 869 3456
Fax: +1 (416) 869 3187

 

Important Dates:
Discounted Registration Deadline
August 14, 2008

Abstract Submission Deadline
August 7, 2008

Abstract Notifications Mailed
September 10, 2008

Abstract Presenter Registration Deadline
October 2, 2008

Regular Registration Deadline
October 8, 2008

Conference Dates
October 16-18, 2008

 

ALUMNI DINNER
A PMH Alumni Dinner is planned for the evening of Friday October 17th.

The PMH Cancer Program will handle Alumni Dinner registration confirmation and payment collection directly.  For questions regarding the Alumni Dinner please contact Sonia Costantino at +1 (416) 946 2380 or pmh50th@uhn.on.ca.

ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com

 

Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.

In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.

©2008 Imedex^®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.

Download the final presentations as presented at:
The 8th Princess Margaret Hospital Conference: Developments in Cancer Management:
Conquering Cancer in our Lifetime

Please click the link after each faculty member's name to download the presentation slides.
Facutly have been listed in alpha order and by the time in which the presentation took place.

Diponkar Banerjee, MBChB, PhD
1330 Banerjee

Michael Barton, MB
0915 Barton

Jerry J. Battista, PhD

Andrea Bezjak, MD
1535 Bezjak

Martin Blackstein, MD, PhD
1615 Blackstein

James Brenton, MD

Patrice Bret, MD
1045 Bret

Robert G. Bristow, MD, PhD
1615 Bristow

Kristy Brock, PhD
1620 Brock

Rena Buckstein, MD
1700 Buckstein

Ann Chambers, PhD
1020 Chambers

Peter Chung, MBChB
1535 Chung

Allan Covens, MD
1440 Covens

Bernard Cummings, MBChB
0900 Cummings

Alastair Cunningham, PhD
1105 Cunningham

Laura A. Dawson, MD
1135 Dawson

Susan Done, MBBChir, PhD
1100 Done

Diane Doran, PhD, RN

William K. Evans, MD
1635 Evans

Peter Ferguson, MD
1445 Fergurson

Anthony Finelli, MD
1645 Finelli

Neil Fleshner, MD, MPH
1415 Fleshner

Michael Friedlander, MD
1020 Friedlander
1130 Friedlander

Anthony Fyles, MD
1120 Fyles
1535 Fyles

Steven Gallinger, MD
1050 gallinger

Mary K. Gospodarowicz, MD
1550 Gospodarowicz

Esther Green, RN
0945 Green

Abha Gupta, MD
1640 Gupta

David W. Hedley, MD
1105 Hedley

Hal W. Hirte, MD
1130 Hirte

David Hodgson, MD
1700 Hodgson

Doris Howell, PhD, RN
0930 Howell

Alan Hudson, MD
0930 Hudson

Jonathan C. Irish, MD
1120 Irish

Alexandro Jadad, MD, DPhil
1105 Jadad

Michael Jewett, MD
1550 Jewett

Kartik Jhaveri, MD
0940 Jhaveri

Michael R. Johnston, MD
1445 Johnston

Erin Kennedy, MD
0920 Kennedy

Rama Khokha, PhD
1050 Khokha

John Kim, MD

Vickie Kong, MRT(T)
1035 Kong

Anne Lee, MD
900 Lee

Fei Fei Liu, MD
1020 Liu

William Mackillop, MD
0815 Mackillop

Leon Massuger, MD, PhD
1040 Massuger

David McCready, MD

Sandra Mitchell, CRNP, AOCN, PhD
1020 Mitchell

Malcolm J. Moore, MD
1120 Moore

Ole Nielsen, MD
1415 Nielsen

Pam Ohashi, PhD
1140 Ohashi

Amita Oza, MD
930 Oza

Bayardo Perez-Ordonez, MD
0945 Perez Ordonez

Eugenia Piliotis, MD
1700 Piliotis

Kathleen I. Pritchard, MD
0900 Pritchard

Michael Rauth, PhD

Donna Reece, MD
1625 Reece

Jolie Ringash, MD
1050 Ringash

Heidi Roberts, MD
1415 Roberts

Gary Rodin, MD
1050 Rodin

Barry Rosen, MD
1625 Rosen

Peter Selby, MD
0815 Selby

Patricia Shaw, MD
1600 Shaw

Frances A. Shepherd, MD
1605 Shepherd -final [Compatibility Mode]

Dietmar Siemann, PhD
0930 Siemann

Lillian L. Siu, MD
1035 Siu

Joyce Slingerland, MD, PhD
0945 Slingerland

Terrence Sullivan, PhD
0900 Sullivan

Simon Sutcliffe, MD
1020 Sutcliffe

Carol Swallow, MD, PhD
1550 Swallow

Ian Tannock, MD, PhD
0815 Tannock
1435 Tannock

Dan Theodorescu, MD, PhD
1330 Theodorescu

Gillian Thomas, MD
1100 Thomas

Lorenz Trümper, MD, PhD
1415 Trumper

Richard Tsang, MD

John Waldron, MD

Padraig Warde, MB
1535 Warde

Robert Weersink, PhD
1650 Weersink

Timothy Whelan, MD
1120 Whelan

William R. Wilson, PhD
0900 Wilson

John W. Wong, PhD
1535 Wong

Martin Yaffe, PhD
0930 Yaffe

Ivan Yeung, PhD
1635 Yeung

John Zalcberg, MB, BS, PhD
1020 Zalcberg

In our continuing effort to provide conference attendees with a permanent copy of the information discussed at this meeting, a summary and/or presentation have been requested from the speakers at this meeting. While every effort has been made to secure this information, in some cases these requests are not fulfilled by a speaker for a variety of reasons. We appreciate your understanding in our quest to provide you with the most updated and complete information possible, and are confident that you will have an enjoyable and educational experience.

 

CORPORATE SUPPORT:
The following companies have provided unrestricted educational grants in support of this Conference:

 

Platinum Corporate   Exhibitor

 

Several options are available to companies interested in supporting this Conference. For more information, please contact Imedex at +1 (770) 751 7332, or by email at cme@imedex.com.